You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME

Managing Metastatic Breast Cancer in the Community Setting: A Clinical Practice Assessment

  • Authors: Harold J. Burstein, MD, PhD
  • CME Released: 8/6/2010
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 8/6/2011
Start Activity


Target Audience and Goal Statement

This activity is intended for medical oncologists, pathologists, and other health professionals who treat patients with metastatic breast cancer.

The goal of this activity is to enable participants to test their current knowledge and skills in the treatment of patients with metastatic breast cancer.

Upon completion of this activity, participants will be able to:

  1. Assess their current approach to clinical management of patients with metastatic breast cancer as it relates to evidence-based practice


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Harold J. Burstein, MD, PhD

    Associate Professor of Medicine, Harvard Medical School; Physician, Dana-Farber Cancer Institute, Boston, Massachusetts

    Disclosures

    Disclosure: Harold J. Burstein, MD, PhD, has disclosed no relevant financial relationships.

    Dr. Burstein does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

    Dr. Burstein does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Margie Miller

    Group Scientific Director, Medscape LLC

    Disclosures

    Disclosure: Margie Miller has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Laurie E. Scudder, DNP, NP

    Accreditation Coordinator, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC; Nurse Practitioner, School-Based Health Centers, Baltimore City Public Schools, Baltimore, Maryland

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Managing Metastatic Breast Cancer in the Community Setting: A Clinical Practice Assessment

Authors: Harold J. Burstein, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 8/6/2010

Valid for credit through: 8/6/2011

processing....

One of the goals of continuing professional development is to acquire and retain knowledge that will affect clinical practice and patient health outcomes. The following case challenge is a clinical self-assessment presented as an educational activity for CME credit. The patient cases are designed to test your current knowledge and skills in the treatment of patients with metastatic breast cancer. Approximately 207,090 new cases of breast cancer are estimated for 2010, with 39,840 deaths anticipated this year. Active research with standard agents has defined better ways to administer available treatments, which, when applied in the clinical setting, can have significant positive effects on patient health outcomes. Moreover, some data that are emerging from studies of investigational therapies indicate that new safe and effective options may be on the horizon, particularly for the most challenging subtypes of breast cancer. We invite you to test your knowledge of metastatic breast cancer in this case challenge, which includes questions addressing treatment choices that should be based on patient history and tumor characteristics. Please note that these questions are designed for assessment, and you are not penalized for answering the questions incorrectly. Data from this survey activity will help facilitate recommendations for future educational activities that will best meet the educational and clinical performance gaps identified. This case-based activity is part of a curriculum series on treatment of metastatic breast cancer. Why not assess your clinical practice and earn CME credit in the process?

Your participation in this initiative is greatly appreciated.

(Please note that this activity is designed to provide feedback only for certain questions in the self-assessment.)

  • Print